Back to School: How biopharma can reboot drug development. Access exclusive analysis here

SGN-15 (BR96): Began Phase II trial

Seattle Genetics Inc., Bothell, Wash.
Product: SGN-15

Read the full 77 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE